| Literature DB >> 35551218 |
Hannah K Levenson1,2, David R Tarpy3,4,5.
Abstract
Shared resources can instigate pathogen spread due to large congregations of individuals in both natural and human modified resources. Of current concern is the addition of pollinator habitat in conservation efforts as it attracts bees of various species, potentially instigating interspecific sharing of pathogens. Common pathogens have been documented across a wide variety of pollinators with shared floral resources instigating their spread in some, but not all, cases. To evaluate the impact of augmented pollinator habitat on pathogen prevalence, we extracted RNA from samples of eight bee species across three families and screened these samples for nine pathogens using RT-qPCR. We found that some habitat characteristics influenced pathogen detection; however, we found no evidence that pathogen detection in one bee species was correlated with pathogen detection in another. In fact, pathogen detection was rare in wild bees. While gut parasites were detected in 6 out of the 8 species included in this study, viruses were only detected in honey bees. Further, virus detection in honey bees was low with a maximum 21% of samples testing positive for BQCV, for example. These findings suggest factors other than the habitat itself may be more critical in the dissemination of pathogens among bee species. However, we found high relative prevalence and copy number of gut parasites in some bee species which may be of concern, such as Bombus pensylvanicus. Long-term monitoring of pathogens in different bee species at augmented pollinator habitat is needed to evaluate if these patterns will change over time.Entities:
Mesh:
Year: 2022 PMID: 35551218 PMCID: PMC9098541 DOI: 10.1038/s41598-022-11734-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
A summary of previous screenings of bees for interspecific pathogen detection.
| Technique | Sample Processing | Reference | Pub. Year | Location | No. of Species | Other | Template (μl) | Max Cycle No | No. of Path. Tested | BQCV | DWV | IAPV | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infection Validation | Pool | [ | 2013 | UK | 1 | * | 1 | 35 | 1 | |||||
| Indiv | [ | 2006 | DE | 2 | * | 5 | 35 | 1 | * | |||||
| [ | 2019 | DE | 24 | * | * | * | NR | 35 | 1 | |||||
| [ | 2019 | CH | 2 | * | * | NR | 40 | 1 | ||||||
| [ | 2020 | N/A | 2 | * | * | 2 | 35 | 1 | ||||||
| [ | 2020 | NL | 2 | * | * | 2 | 40 | 3 | * | |||||
| RT | Pool | [ | 2013 | AR | 1 | * | 5 | 40 | 7 | * | * | * | ||
| [ | 2016 | BE | 4 | * | * | 1 | 35 | 12 | ||||||
| [ | 2017 | CA | 2 | * | * | 2 | 40 | 7 | * | * | * | |||
| [ | 2018 | BE | 8 | * | * | 1 | 35 | 10 | * | |||||
| [ | 2020 | TX, US | 15 | * | NR | 30 | 6 | * | * | * | ||||
| [ | 2021 | FR | 30 | * | * | * | NR | 35 | 7 | |||||
| Both | [ | 2011 | JP | 2 | * | NR | 35 | 7 | * | * | * | |||
| [ | 2013 | EU | 3 | * | 1–2 | NR | 9 | * | ||||||
| [ | 2014 | BE | 6 | * | * | 1–3 | 35 | 16 | * | * | ||||
| r-t | Indiv | [ | 2009 | AR | 6 | * | 5 | 30 | 4 | |||||
| [ | 2012 | UK | 17 | * | * | * | 1 | 40 | 4 | * | ||||
| [ | 2014 | EN | 7 | * | 5 | 35 | 6 | * | ||||||
| [ | 2015 | N/A | 2 | * | * | 1–2 | 35 | 5 | * | |||||
| [ | 2018 | US | 28 | * | 1 | 40 | 3 | |||||||
| [ | 2020 | NY, US | 9 | * | * | * | 1 | 40 | 5 | |||||
| RT | [ | 2012 | PA, US | 15 | * | * | NR | 38 | 5 | * | * | * | ||
| [ | 2011 | UT, US | 1 | * | NR | 40 | 1 | * | ||||||
| [ | 2013 | PA, US | 30 | * | * | 5 | 38 | 5 | * | * | * | |||
| [ | 2014 | G.B | 2 | * | * | NR | NR | 2 | * | |||||
| [ | 2015 | CO | 1 | * | 1 | 35 | 10 | * | * | |||||
| [ | 2017 | DE | 33 | * | * | * | NR | 40 | 6 | * | ||||
| [ | 2019 | NY, US | 2 | * | * | NR | NR | 3 | * | * | ||||
| [ | 2020 | NZ | 24 | * | * | * | 1 | 35 | 5 | * | * | |||
| [ | 2020 | NE, US | 4 | * | * | 2.5 | 40 | 4 | * | * | * | |||
| [ | 2021 | MI, US | 4 | * | * | * | 2–2.5 | 37 | 3 | |||||
| Both | [ | 2018 | PL | 4 | * | 1–3 | 35 | 6 | * | |||||
| [ | 2019 | AR | 3 | * | 5 | 35 | 10 | * | * | * | ||||
| RT | Both | [ | 2019 | IT | 1 | * | 5 | 50 | 7 | * | * |
A two-letter code is used for each country, with a two-letter state code also included for US projects. The total number of bee species tested is shown, followed by if certain common species were included. Similarly, the total number of pathogens tested is shown, followed by if certain commonly tested for pathogens were included. This table shows papers that tested for infection validation or used ‘traditional’ PCR techniques (real time PCR [r-t], reverse transcription [RT] PCR, or Both r-t and RT) only. When a piece of information was not reported, it is shown as NR in the table. Max cycle number refers to the cycle number used during PCR analysis.
1This paper used capillary electrophoresis to score their RT-PCR.
Similar to Table 1, this table summarizes previous screenings of bees for interspecific pathogen detection.
| Standard Used | Sample Processing | Reference | Pub. Year | Location | No. of Species | Other | Template (μl) | Max Cycle No | No. of Path. Tested | BQCV | DWV | IAPV | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No | Pool | [ | 2011 | UT, US | 1 | * | NR | 30 | 1 | * | ||||
| [ | 2015 | MX | 1 | * | 1 | 40 | 10 | * | * | |||||
| [ | 2021 | PA, US | 3 | * | * | * | 2 | 35 | 5 | * | * | |||
| Yes | [ | 2016 | IA, US | 5 | * | * | NR | 40 | 5 | * | * | |||
| [ | 2018 | IT | 1 | * | 5 | 50 | 1 | * | ||||||
| [ | 2019 | VT, US | 3 | * | * | NR | 40 | 3 | * | * | * | |||
| No | Indiv | [ | 2020 | PE; BO | 3 | * | NR | NR | 5 | |||||
| Yes | [ | 2015 | G.B | 2 | * | * | NR | 40 | 6 | * | * | |||
| [ | 2018 | UK | 5 | * | * | 2–2.5 | 45 | 5 | * | |||||
| [ | 2021 | IA, US | 3 | * | * | NR | 45 | 3 | ||||||
| Both | This paper | 2022 | NC, US | 8 | * | * | * | 1 | 40 | 9 | * | * | * |
This table shows papers that used quantified PCR techniques only and notes if each paper included a standard curve during analysis.
1This paper used qPCR.
2This paper used RT-PCR for some targets and RT-qPCR for others.
A summary of the number of individuals and pools screened for each bee species during pathogen analysis.
| Sample Number | Number of Samples with Positive Detections | Number of Pathogens | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Species | Sample Status | Screened | Total Individuals | ABPV | BQCV | CBPV | DWVa | DWVb | IAPV | LSV | Total Detected | ||
| Individual | 189 | 189 | 1 | 40 | – | 32 | 8 | 1 | 27 | 26 | 22 | 8 | |
| Individual | 201 | 201 | – | – | – | – | – | – | – | 68 | 1 | 2 | |
| Pooled | 19 | 31 | – | – | – | – | – | – | – | 6 | 5 | 2 | |
| Pooled | 58 | 260 | – | – | – | – | – | – | – | 6 | – | 1 | |
| Pooled | 2 | 3 | – | – | – | – | – | – | – | – | – | 0 | |
| Pooled | 12 | 28 | – | – | – | – | – | – | – | 1 | 1 | 2 | |
| Individual | 1 | 1 | – | – | – | – | – | – | – | 1 | – | 1 | |
| Individual | 20 | 20 | – | – | – | – | – | – | – | – | – | 0 | |
| Totals | 502 | 733 | 1 | 40 | 0 | 32 | 8 | 1 | 27 | 108 | 29 | ||
The number of samples screened, total number of samples included, number of positive detections for each pathogen, and total number of pathogens detected are shown.
Figure 1Visual comparison of viral matrices. Each block shows samples from a particular location with A. mellifera (Am) [on the left-hand matrix of each block] and B. impatiens (Bi) [on the right-hand matrix]. Samples from 2017 are displayed at the top of each block and 2018 on the bottom. Each row represents an individual sample, and each column represents a different target listed in alphabetical order (A = ABPV; B = BQCV; C = CBPV; Da = DWVa; Db = DWVb; I = IAPV; L = LSV; T = Try. spp.; and N = Nos. spp.). Relative intensity is represented with a color gradient from low (bright yellow) to high (bright red). This figure was created using Adobe Illustrator, Microsoft Excel, and Microsoft Word. Thank you to Kirsten Benson for creating the base map.
Figure 3Copy number per 1 µl of template (approximately 3.3 ng of RNA) of Trypanosome spp. for A. mellifera, B. impatiens, and B. pensylvanicus across the sampling season.
Figure 2Copy number per 1 µl of template (approximately 3.3 ng of RNA) of Trypanosome spp. for A. mellifera, B. impatiens, and B. pensylvanicus across the different levels of flower cover.